Summarizing historical information on controls in clinical trials

样本量测定 临床试验 统计 样品(材料) 随机对照试验 计算机科学 计量经济学 医学 数学 内科学 化学 色谱法
作者
Beat Neuenschwander,Gorana Capkun-Niggli,Michael Branson,David J. Spiegelhalter
出处
期刊:Clinical Trials [SAGE Publishing]
卷期号:7 (1): 5-18 被引量:294
标识
DOI:10.1177/1740774509356002
摘要

Historical information is always relevant when designing clinical trials, but it might also be incorporated in the analysis. It seems appropriate to exploit past information on comparable control groups.Phase IV and proof-of-concept trials are used to discuss aspects of summarizing historical control data as prior information in a new trial. The importance of a fair assessment of the similarity of control parameters is emphasized.The methodology is meta-analytic-predictive. Heterogeneity of control parameters is expressed via the between-trial variation, which is the key parameter determining the prior effective sample size and its upper bound (prior maximum sample size).For a Phase IV trial (930 control patients in 11 historical trials) between-trial heterogeneity was fairly small, resulting in a prior effective sample size of approximately 90 patients. For a proof-of-concept trial (363 patients in four historical trials) heterogeneity was moderate to substantial, resulting in a prior effective sample size of approximately 20. For another proof-of-concept trial (14 patients in one historical trial), assuming substantial heterogeneity implied a prior effective sample size of 7. The prior effective sample size can only be large if the amount of historical data is large and between-trial heterogeneity is small. The prior effective sample size is bounded by the prior maximum sample size (ratio of within- to between-trial variance), irrespective of the amount of historical data.The meta-analytic-predictive approach assumes exchangeability of control parameters across trials. Due to the difficulty to quantify between-trial variability, sensitivity of conclusions regarding assumptions and type of inference should be assessed.The use of historical control information is a valuable option and may lead to more efficient clinical trials. The proposed approach is attractive for nonconfirmatory trials, but under certain circumstances extensions to the confirmatory setting could be envisaged as well.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
风不留痕发布了新的文献求助10
2秒前
美满的幻悲完成签到,获得积分10
5秒前
leeSongha完成签到 ,获得积分10
6秒前
Yu完成签到,获得积分10
7秒前
cdercder应助风不留痕采纳,获得10
11秒前
JUAN完成签到,获得积分10
12秒前
清脆的问雁完成签到,获得积分10
14秒前
郑征完成签到,获得积分10
15秒前
17秒前
zhangyx完成签到 ,获得积分0
20秒前
感性的伟诚完成签到 ,获得积分10
20秒前
wang5945发布了新的文献求助10
22秒前
自由月亮完成签到,获得积分10
24秒前
认真学飞雷神的林克完成签到,获得积分20
26秒前
张庭豪完成签到,获得积分10
26秒前
27秒前
28秒前
31秒前
YiLu发布了新的文献求助10
31秒前
Coisini发布了新的文献求助10
31秒前
贪玩定帮完成签到,获得积分10
32秒前
ANSWERM完成签到 ,获得积分10
33秒前
肥猫发布了新的文献求助10
33秒前
SCI的芷蝶完成签到 ,获得积分10
35秒前
李爱国应助wang5945采纳,获得10
38秒前
去小岛上流浪完成签到,获得积分10
39秒前
岩松完成签到 ,获得积分10
41秒前
开朗醉波完成签到,获得积分10
43秒前
cdercder应助Ogerpon采纳,获得10
46秒前
幽默鱼完成签到,获得积分10
46秒前
goodjust完成签到 ,获得积分10
47秒前
务实笑柳完成签到 ,获得积分10
48秒前
猪哥完成签到 ,获得积分10
48秒前
许自通完成签到,获得积分10
48秒前
小巧世倌完成签到,获得积分10
48秒前
花生了什么树完成签到 ,获得积分10
50秒前
Akim应助科研通管家采纳,获得10
52秒前
酷波er应助科研通管家采纳,获得10
52秒前
margaret完成签到 ,获得积分10
56秒前
zhangjj28完成签到,获得积分10
57秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 2500
Atlas of Aligner Treatment and Planning A Case-Based Approach 1000
悉尼大学博士学位论文,题目:Modelling and testing of one-sided stitched laminated composites. 作者:Kristopher P. Plain 700
Soil mites of the family Rhagidiidae (Actinedida: Eupodoidea). Morphology, Systematics, Ecology 520
Matrix Methods in Data Mining and Pattern Recognition Second Edition 510
丝光沸石活性位点定向调控及其二甲醚羰基化性能研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7432707
求助须知:如何正确求助?哪些是违规求助? 9034383
关于积分的说明 19246022
捐赠科研通 7058943
什么是DOI,文献DOI怎么找? 3236604
关于科研通互助平台的介绍 2400227
邀请新用户注册赠送积分活动 2219806